2022

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49 Neoplasms
    3. ›
  3. C60-C63 Malignant neoplasms of male genital organs
    4. ›
  4. C63- Malignant neoplasm of other and unspecified male genital organs
    5. ›
  5. 2022 ICD-10-CM Diagnosis Code C63.7

2022 ICD-10-CM Diagnosis Code C63.7

Malignant neoplasm of other specified male genital organs

    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Male Dx
  • C63.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2022 edition of ICD-10-CM C63.7 became effective on October 1, 2021.
  • This is the American ICD-10-CM version of C63.7 - other international versions of ICD-10 C63.7 may differ.
ICD-10-CM Coding Rules
  • C63.7 is applicable to male patients.
Applicable To
  • Malignant neoplasm of seminal vesicle
  • Malignant neoplasm of tunica vaginalis
The following code(s) above C63.7 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C63.7:
  • C00-D49
    2022 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C60-C63
    2022 ICD-10-CM Range C60-C63

    Malignant neoplasms of male genital organs

    Includes
    • malignant neoplasm of skin of male genital organs
    Malignant neoplasms of male genital organs
ICD-10-CM C63.7 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
  • 715 Other male reproductive system o.r. Procedures for malignancy with cc/mcc
  • 716 Other male reproductive system o.r. Procedures for malignancy without cc/mcc
  • 722 Malignancy, male reproductive system with mcc
  • 723 Malignancy, male reproductive system with cc
  • 724 Malignancy, male reproductive system without cc/mcc

Convert C63.7 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
Code annotations containing back-references to C63.7:
  • Type 1 Excludes: C61
    ICD-10-CM Diagnosis Code C61

    Malignant neoplasm of prostate

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Male Dx
    Type 1 Excludes
    • malignant neoplasm of seminal vesicle (C63.7)
    Use Additional
    • code to identify:
    • hormone sensitivity status (Z19.1-Z19.2)
    • rising PSA following treatment for malignant neoplasm of prostate (R97.21)
ICD-10-CM Codes Adjacent To C63.7
C63 Malignant neoplasm of other and unspecified male genital organs
C63.0 Malignant neoplasm of epididymis
C63.00 Malignant neoplasm of unspecified epididymis
C63.01 Malignant neoplasm of right epididymis
C63.02 Malignant neoplasm of left epididymis
C63.1 Malignant neoplasm of spermatic cord
C63.10 Malignant neoplasm of unspecified spermatic cord
C63.11 Malignant neoplasm of right spermatic cord
C63.12 Malignant neoplasm of left spermatic cord
C63.2 Malignant neoplasm of scrotum
C63.7 Malignant neoplasm of other specified male genital organs
C63.8 Malignant neoplasm of overlapping sites of male genital organs
C63.9 Malignant neoplasm of male genital organ, unspecified
C64 Malignant neoplasm of kidney, except renal pelvis
C64.1 Malignant neoplasm of right kidney, except renal pelvis
C64.2 Malignant neoplasm of left kidney, except renal pelvis
C64.9 Malignant neoplasm of unspecified kidney, except renal pelvis
C65 Malignant neoplasm of renal pelvis
C65.1 Malignant neoplasm of right renal pelvis
C65.2 Malignant neoplasm of left renal pelvis
C65.9 Malignant neoplasm of unspecified renal pelvis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com